000			01704nam a22001577a 4500
999			_c522524 _d522524
008			230419b ||||| |||| 00| 0 eng d
100			_aChoudhary, Priyanka and Singh, Vijay Kumar _940121
245			_aPublic policy and prospects of pharmaceutical MSMES: A study with special reference to Dehradunn, Uttrakhand
260			_aBihar Journal of Public Administration
300			_a19(2), Jul-Dec, 2022: p.236-247
520			_aMicro, Small and Medium Enterprises (MSMEs) are the major contributors to the GDP of India and among them the MSMEs involved in pharmaceutical industry are the most viable enterprises. It is indeed a bonanza for developing economies like India. But these MSMEs were the worst sufferers during the Covid-19 pandemic. Considering the significant contribution of MSMEs to the country’s overall economic growth, the government has announced a slew of measures under ‘Atmanirbhar Bharat’ to improve their productivity and sustainability to cope up the losses. One such initiative of the government is the Production Linked Incentive Scheme (PLI), which has been launched to incentivize the global and domestic players to enhance investment and production of drugs and high-value products in bulk. Thus, the present paper is an attempt to analyze and identify the issues and challenges in the pharmaceutical MSME sector with special reference to Dehradun, Uttarakhand, all in the context of public policies like Atmanirbhar Bharat and PLI schemes.- Reproduced
650			_aMSMEs, Atmanirbhar Bharat, PLI schemes, Pharmaceuticals, Uttrakhand. _937715
773			_aBihar Journal of Public Administration
906			_aMICRO SMALL AND MEDIUM ENTERPRISES
942			_cAR